From October 1, 2023 to December 31, 2023, the company has repurchased 777,528 shares, representing 0.46% for CNY 82.13 million. With this, the company has completed the repurchase of 1,089,486 shares, representing 0.64% for CNY 117.15 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
42.6 HKD | +0.71% | -0.47% | +5.46% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.46% | 1.92B | |
-4.98% | 182B | |
+2.84% | 112B | |
-2.68% | 68.58B | |
+4.53% | 51.58B | |
+8.00% | 44.24B | |
+9.65% | 43.65B | |
+25.30% | 32.46B | |
-0.17% | 25.61B | |
+21.57% | 25.99B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.